Authors
Loading...
Randomized trial characterizes immune-cell infiltration and metabolic markers in canine prostate carcinoma, suggesting extensive immune involvement without predictive clinical outcomes.
Kato et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: